A Risk-Adjusted Approach to Comparing the Return on Investment in Health Care Programs

[1]  G. Vechkanov Investments , 2014, Canadian Medical Association journal.

[2]  Amiram Gafni,et al.  Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations. , 2004, Social science & medicine.

[3]  Maiwenn J Al,et al.  Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty. , 2003, Social science & medicine.

[4]  M. Al Evaluating health care technologies: Certain methods for uncertain situations , 2001 .

[5]  J. Zivin Cost-effectiveness analysis with risk aversion. , 2001, Health economics.

[6]  C. Murray,et al.  Stochastic league tables: communicating cost-effectiveness results to decision-makers. , 2001, Health economics.

[7]  C. Bell,et al.  A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  B. O'brien,et al.  Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules. , 2000, Medical care.

[9]  A Briggs,et al.  Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.

[10]  John Mullahy,et al.  Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .

[11]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[12]  K. Arrow,et al.  Uncertainty and the Evaluation of Public Investment Decisions , 1994 .

[13]  A. Gafni,et al.  Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems. , 1993, Journal of health economics.

[14]  M. Drummond,et al.  Cost-effectiveness league tables: more harm than good? , 1993, Social science & medicine.

[15]  M. Drummond,et al.  Some guidelines on the use of cost effectiveness league tables. , 1993, BMJ.

[16]  A Gafni,et al.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? , 1992, Journal of health economics.

[17]  A Gafni,et al.  Opportunity costs and uncertainty in the economic evaluation of health care interventions. , 2002, Health economics.

[18]  J. Bridges,et al.  Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies , 2001, The European Journal of Health Economics.